Ultralife (NASDAQ:ULBI - Get Free Report) will be releasing its earnings data before the market opens on Friday, November 8th. Persons interested in listening to the company's earnings conference call can do so using this link.
Ultralife Price Performance
Shares of NASDAQ ULBI traded up $0.14 during mid-day trading on Friday, reaching $8.55. The company had a trading volume of 68,660 shares, compared to its average volume of 79,064. The company has a current ratio of 4.07, a quick ratio of 2.06 and a debt-to-equity ratio of 0.07. The stock has a market cap of $142.10 million, a PE ratio of 14.25 and a beta of 0.97. The company has a 50-day moving average price of $9.40 and a two-hundred day moving average price of $10.33. Ultralife has a 1-year low of $6.36 and a 1-year high of $13.39.
Wall Street Analyst Weigh In
Separately, StockNews.com cut Ultralife from a "strong-buy" rating to a "buy" rating in a report on Thursday, October 3rd.
Check Out Our Latest Stock Analysis on ULBI
Ultralife Company Profile
(
Get Free Report)
Ultralife Corporation, together with its subsidiaries, designs, manufactures, installs, and maintains power, and communication and electronics systems worldwide. The company operates in two segments, Battery & Energy Products and Communications Systems. The Battery & Energy Products segment offers lithium 9-volt, cylindrical, thin lithium manganese dioxide, rechargeable, and other non-rechargeable batteries; lithium-ion cells, multi-kilowatt module lithium-ion battery systems, and uninterruptable power supplies; and rugged military and commercial battery charging systems and accessories, including smart chargers, multi-bay charging systems, and various cables.
Further Reading
Before you consider Ultralife, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Ultralife wasn't on the list.
While Ultralife currently has a "Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Options trading isn’t just for the Wall Street elite; it’s an accessible strategy for anyone armed with the proper knowledge. Think of options as a strategic toolkit, with each tool designed for a specific financial task. Keep reading to learn how options trading can help you use the market’s volatility to your advantage.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
